Immunopathogenesis and treatment of myasthenia gravis.
D000818:Animals; D001323:Autoantibodies / Q000276:immunology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004195:Disease Models, Animal; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D007167:Immunotherapy; D009157:Myasthenia Gravis / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D009469:Neuromuscular Junction / Q000276:immunology / Q000503:physiopathology; D011950:Receptors, Cholinergic / Q000276:immunology / Q000502:physiology; D009435:Synaptic Transmission; D013950:Thymus Gland / Q000276:immunology
D001323:Autoantibodies; D002800:Cholinesterase Inhibitors; D007130:Immunoglobulin Idiotypes; D011950:Receptors, Cholinergic